Development
A neoantigen vaccine to prevent colon cancer clears early trials
Claim
A proof-of-concept neoantigen vaccine to prevent colon cancer showed strong immune responses and safety in early human trials.
Reporting date: (not necessarily the event date)
Sources
Attribution and reporting linked by this record; links do not imply independent verification.
- Welcome to January 24, 2026 (theinnermostloop.substack.com)
Cite or correct this record
Suggest a correction — opens a GitHub draft for you to review and submit.